Novo Nordisk A/S continued to enjoy strong revenue from its diabetes franchise in the 2011 first quarter with sales up by 15% in Danish kroner and 11% in local currencies. The operating profit rose by 24%, giving an operating margin of 34.5%. ---Subscribe to MedNous to access this article--- Company News
